As some psychedelics advocates have vowed to redouble their state-by-state policy reform efforts in light of Lykos Therapeutics’ FDA rejection this summer, we’re renewing our own efforts to cover such activity.Long-time readers will know that we launched our U.S. Psychedelic Legalization & Decriminalization Tracker back in 2021 and our Worldwide equivalent a short time later. More recently…
